Results 161 to 170 of about 15,044 (185)
Some of the next articles are maybe not open access.
The Lancet Neurology, 2004
Corticobasal degeneration is a progressive neurodegenerative disease that typically presents with asymmetrical parkinsonism and cognitive dysfunction. Recent molecular advances have given some clues to the pathogenesis of the disease. Clinical diagnosis is complicated by both the variability of presentation of true corticobasal degeneration, for ...
Robert K, Mahapatra +3 more
+7 more sources
Corticobasal degeneration is a progressive neurodegenerative disease that typically presents with asymmetrical parkinsonism and cognitive dysfunction. Recent molecular advances have given some clues to the pathogenesis of the disease. Clinical diagnosis is complicated by both the variability of presentation of true corticobasal degeneration, for ...
Robert K, Mahapatra +3 more
+7 more sources
Current Treatment Options in Neurology, 2003
Corticobasal degeneration is one of the neurodegenerative tauopathies, which are defined as a group of heterogeneous dementias and movement disorders that are characterized neuropathologically by prominent intracellular accumulations of abnormal filaments formed by the microtubule-associated protein tau.
Panida, Piboolnurak, Cheryl H., Waters
openaire +3 more sources
Corticobasal degeneration is one of the neurodegenerative tauopathies, which are defined as a group of heterogeneous dementias and movement disorders that are characterized neuropathologically by prominent intracellular accumulations of abnormal filaments formed by the microtubule-associated protein tau.
Panida, Piboolnurak, Cheryl H., Waters
openaire +3 more sources
Seminars in Neurology, 2001
Corticobasal degeneration (CBG) is an increasingly recognized neurodegenerative disease with both motor and cognitive dysfunction. The diagnosis is probably underestimated because of the heterogeneity of clinical features, overlap with symptoms, and pathologic findings of other neurodegenerative diseases.
N P, Stover, R L, Watts
openaire +3 more sources
Corticobasal degeneration (CBG) is an increasingly recognized neurodegenerative disease with both motor and cognitive dysfunction. The diagnosis is probably underestimated because of the heterogeneity of clinical features, overlap with symptoms, and pathologic findings of other neurodegenerative diseases.
N P, Stover, R L, Watts
openaire +3 more sources
Seminars in Neurology, 2014
Among the atypical parkinsonian syndromes, corticobasal degeneration (CBD) is probably the most challenging disorder to diagnose antemortem. It can present with multiple phenotypes, none of them specific enough to lead to an unequivocal diagnosis. Alternatively, multiple other neurodegenerative disorders with a different underlying pathology, such as ...
Ana M, Grijalvo-Perez, Irene, Litvan
openaire +3 more sources
Among the atypical parkinsonian syndromes, corticobasal degeneration (CBD) is probably the most challenging disorder to diagnose antemortem. It can present with multiple phenotypes, none of them specific enough to lead to an unequivocal diagnosis. Alternatively, multiple other neurodegenerative disorders with a different underlying pathology, such as ...
Ana M, Grijalvo-Perez, Irene, Litvan
openaire +3 more sources
Brain, 1989
Three patients with clinical and pathological features of corticobasal degeneration are described. They presented with a progressive disease bearing some clinical resemblance to Steele-Richardson-Olszewski syndrome and displaying some pathological features of Pick's disease.
W R, Gibb, P J, Luthert, C D, Marsden
openaire +2 more sources
Three patients with clinical and pathological features of corticobasal degeneration are described. They presented with a progressive disease bearing some clinical resemblance to Steele-Richardson-Olszewski syndrome and displaying some pathological features of Pick's disease.
W R, Gibb, P J, Luthert, C D, Marsden
openaire +2 more sources
Dystonia in corticobasal degeneration
Movement Disorders, 2001AbstractOBJECTIVE:To characterize the clinical features, particularly dystonia, in patients with clinically diagnosed or pathologically proven corticobasal degeneration (CBD).BACKGROUND:Although dystonia has been reported in many neurodegenerative disorders, it has not been studied in CBD.
Z, Vanek, J, Jankovic
openaire +3 more sources
Neurology, 1997
We investigated clinical and neuropathologic heterogeneity and apolipoprotein E (apoE) genotype in 11 cases of neuropathologically diagnosed corticobasal degeneration (CBD). Although seven of the 11 patients presented with unilateral limb dysfunction, the remaining four patients had less typical presentations including memory loss, behavioral changes ...
J A, Schneider +4 more
openaire +2 more sources
We investigated clinical and neuropathologic heterogeneity and apolipoprotein E (apoE) genotype in 11 cases of neuropathologically diagnosed corticobasal degeneration (CBD). Although seven of the 11 patients presented with unilateral limb dysfunction, the remaining four patients had less typical presentations including memory loss, behavioral changes ...
J A, Schneider +4 more
openaire +2 more sources
Myoclonus in corticobasal degeneration
Movement Disorders, 1997AbstractFive patients with unilateral myoclonus and a clinical diagnosis of corticobasal degeneration (CBD) were studied. All patients showed enhanced long‐loop responses in their myoclonic arms without enlarged somatosensory potentials. The cortical relay time of the long‐loop responses was studied in three patients, in two of whom it was <2 ms ...
F, Carella +3 more
openaire +2 more sources
CORTICOBASAL SYNDROME AND CORTICOBASAL DEGENERATION
Journal of Neurology, Neurosurgery & Psychiatry, 2016Corticobasal degeneration (CBD) typically presents with asymmetric dyspraxia, stiffness and dystonia (Corticobasal syndrome – CBS). Features of CBS occur in other diseases and there are no well validated clinical or biological markers that accurately predict its underlying pathology, making diagnosis difficult.
Ruth Lamb +5 more
openaire +1 more source